Rua Bioscience Limited (RUA.NZ)

NZD 0.03

(0.0%)

Market Cap (In NZD)

11.46 Million

Revenue (In NZD)

85.83 Thousand

Net Income (In NZD)

-13.71 Million

Avg. Volume

168.68 Thousand

Currency
NZD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.023-0.121
PE
-
EPS
-
Beta Value
0.228
ISIN
NZRUAE0004S1
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Paul Naske
Employee Count
-
Website
https://www.ruabio.com
Ipo Date
2020-10-21
Details
Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. It offers cannabinoid derived medicines. The company was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. Rua Bioscience Limited was founded in 2016 and is based in Gisborne, New Zealand.